Climb Bio, Inc. (CLYM)
5.67
+0.40
(+7.59%)
USD |
NASDAQ |
Feb 13, 16:00
5.68
+0.01
(+0.18%)
After-Hours: 20:00
Climb Bio EPS Diluted (Quarterly) : -0.1895 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Fortress Biotech, Inc. | 0.111 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Lyell Immunopharma, Inc. | -2.126 |
| PepGen Inc. | -0.5246 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.89M |
| Total Expenses (Quarterly) | 12.89M |
| Enterprise Value | 300.28M |
| Earnings Yield | -13.24% |
| Normalized Earnings Yield | -13.24 |